Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Lines”

84 trials

Showing 20 of 84 results

Large-scale testing (Phase 3)Study completedNCT03014635
What this trial is testing

Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 306
Testing effectiveness (Phase 2)Study completedNCT04096326
What this trial is testing

AGN-151586 Dose-Ranging Study for Treatment of Glabellar Lines

Who this might be right for
Glabellar Lines
Allergan 198
Large-scale testing (Phase 3)Study completedNCT00770211
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 271
Early research (Phase 1)Study completedNCT05428930
What this trial is testing

Safety and Efficacy of CKDB-501B in Subjects With Moderate-to-severe Glabellar Lines

Who this might be right for
Glabellar Lines
CKD Bio Corporation 30
Large-scale testing (Phase 3)UnknownNCT05623410
What this trial is testing

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 300
Testing effectiveness (Phase 2)Study completedNCT03806933
What this trial is testing

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Aesthetics GmbH 241
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT04249583
What this trial is testing

Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 300
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Testing effectiveness (Phase 2)Study completedNCT05100199
What this trial is testing

The Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines

Who this might be right for
Glabellar Lines
Allergan 328
Large-scale testing (Phase 3)Study completedNCT02353871
What this trial is testing

Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Ipsen 185
Post-approval studies (Phase 4)Study completedNCT02718118
What this trial is testing

Comparison of Dysport Reconstitution at 1.5 mL and 2.5 mL for the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesWrinkles
Galderma R&D 60
Early research (Phase 1)Study completedNCT04944953
What this trial is testing

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 38
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)Study completedNCT01629875
What this trial is testing

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Who this might be right for
Moderate to Severe Glabellar Line
Daewoong Pharmaceutical Co. LTD. 268
Testing effectiveness (Phase 2)Study completedNCT02961673
What this trial is testing

The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Lines
Huons Co., Ltd. 57
Not applicableStudy completedNCT05481931
What this trial is testing

Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 756
Large-scale testing (Phase 3)Looking for participantsNCT07435428
What this trial is testing

Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

Who this might be right for
Moderate to Severe Glabellar Lines
Ipsen 1,300
Testing effectiveness (Phase 2)Study completedNCT01333397
What this trial is testing

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Ipsen 176
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation